People taking two common types of drugs for hypertension are at no heightened risk, as has been feared, for increased severity or complications of COVID-19.
Author: Bruce Goldman
Enlisting the entire immune system strengthens potency of HIV vaccines in development
Two recent Stanford-led studies show the value of tweaking vaccines to enlist the entire immune system — not just part of it — in preventing HIV infection.
How remdesivir works, and why it’s not the ultimate coronavirus killer
How exactly does the antiviral drug remdesivir counter SARS-CoV-2 – the coronavirus strain responsible for COVID-19? And how well?
COVID-19 adds urgency to synthetic film that aids breathing
The COVID-19 pandemic gives new relevance to a synthetic substance developed by Stanford researchers that could help respiratory patients breathe easier.
Brain imaging for stroke patients dropped off during COVID-19 height
In U.S. hospitals, the frequency of brain imaging for acute stroke patients dipped, suggesting hesitancy to seek medical care for non-COVID-19 conditions.
How chloroquine, coronavirus duke it out inside a dish
Even if chloroquine and hydroxychloroquine don't end up being the best treatment for COVID-19, observing how they work in a dish can teach scientists a lot.
Gel smooths cells’ ride through syringes in regenerative therapy
An innovative stem cell delivery method vastly improves the viability of tissue regenerating cells in animal spinal-cord injury models.
What’s a virus, anyway? Part 2: How coronaviruses infect us — and how viruses created us
A look at how viruses — including coronavirus — enter cells, use their molecular machinery to copy themselves and escape. And how to stop them.
What’s a virus, anyway? Part 1: The bare-bones basics
Amid the COVID-19 pandemic, viruses are getting a lot of attention; here's an inside look into the most abundant life form on Earth.
Macular degeneration steals sight. A chip implant may get it back.
In a clinical trial, a tiny prosthetic retinal device invented by a Stanford researcher has proved its potential ability to restore eyesight to the blind.
Identification of “missing microbe” spurs clinical trial in ulcerative colitis
A study links ulcerative colitis to the depletion of important acids ordinarily produced by a set of gut microbes mysteriously missing in action.
When things go wrong with mitochondria
Cellular respiration has a downside: Its byproducts harm the mitochondria that perform this trick, endangering our brain cells.
Suspicion: Why are virus-targeting immune cells sniffing around Alzheimer’s patients’ brains?
A new study has identified T cells targeting the Epstein-Barr virus in autopsied Alzheimer's brains and in cerebrospinal fluid of Alzheimer's patients.
Can Ecstasy be repurposed to catalyze the patient/psychotherapist bond?
Stanford researchers have teased apart the addictive and pro-social effects of MDMA -- suggesting the possibliity of a non-addictive therapy.
Why we talk with our hands — and how that may help give speech to the speechless
Stanford researchers found that the same part of the motor cortex that controls hand movement also appears to influence muscles used for talking.
How estrogen cycles change female mice’s (and possibly people’s) brains, governing sexual receptivity
A discovery about how a neural circuit located deep in the brains of female mice changes in response to estrogen could offer insight into human brains.